Oxford BioMedica PLC (OXBDF): Oxford Biomedica To Get Milestone Paymen...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	138
Posts	23702
Boards Moderated	0
Alias Born	04/08/2004

georgejjl

Re: None

Tuesday, 04/30/2019 7:45:52 PM

Tuesday, April 30, 2019 7:45:52 PM

Oxford Biomedica To Get Milestone Payment As Axovant Doses Patient LONDON (Alliance News) - Oxford Biomedica on Tuesday said that Axovant Gene Therapies Ltd has ...
Alliance News30 April, 2019 | 5:24PMEmail Form
LONDON (Alliance News) - Oxford Biomedica on Tuesday said that Axovant Gene Therapies Ltd has triggered a USD15 million milestone payment to the company.

Axovant has announced the dosing of the first patient of the second cohort in the Sunrise-PD phase two trial of AXO-Lenti-PD in Parkinson's disease patients, Oxford Biomedica said, which has triggered the payment to the London-listed firm under an agreement signed in June.

Up to six patients will be dosed in this second cohort, Oxford Biomedica said. To date, the patient has experienced no complications related to the surgery or to administration of the vector and has been discharged home as planned.

Oxford Biomedica shares closed down 0.1% at 697.073 pence on Tuesday.

http://www.morningstar.co.uk/uk/news/AN_1556641470134623300/oxford-biomedica-to-get-milestone-payment-as-axovant-doses-patient.aspx

Good luck and GOD bless,